Application of self-organizing maps for the detection and classification of human blood plasma lipoprotein lipid profiles on the basis of 1H NMR spectroscopy data

NMR in Biomedicine

Volumn 11, Issue 4-5, 1998, Pages 168-176

  Kaartinen, J ^a   Hiltunen, Y ^a   Kovanen, P T ^b   Ala Korpela, M ^b  

^a Raahe Inst of Computer Engineering   (Finland)

^b WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Coronary heart disease; Fuzzy logic; Kohonen maps; Neural networks; Risk assessment

Indexed keywords

ANALYTIC METHOD; ARTICLE; CORONARY ARTERY DISEASE; DATA ANALYSIS; DECISION MAKING; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MODEL; NERVE CELL NETWORK; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT;

CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; DATA DISPLAY; DATA INTERPRETATION, STATISTICAL; HUMANS; LIPIDS; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTONS; RISK FACTORS; TRIGLYCERIDES;

EID: 0031902291     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199806/08)11:4/5<168::AID-NBM527>3.0.CO;2-K     Document Type: Article

References (38)

1. Gillies R. J., ed. NMR in Physiology and Biomedicine, Academic Press, San Diego (1994).
2. 1H MRSI using time-domain fitting and neural network classification. Magn. Reson. Imag. 11, 1019-1026 (1993).
3. Kohonen T. Self-organizing Maps. Springer, Heidelberg (1995).
4. Zupan J. and Gasteiger J. Neural networks: a new method for solving chemical problems or just a passing phase? Anal. Chim. Acta 248, 1-30 (1991).
5. 1H nuclear magnetic resonance spectra by the application of chemometric techniques. Magn. Reson. Med. 28, 214-236 (1992).
6. 31P magnetic resonance spectroscopy tumour spectra obtained in vivo. NMR Biomed. 6, 237-241 (1993).
7. 1H NMR spectra of urine using an artificial neural network. J. Pharmaceut. Biomed. Anal. 13, 205-211 (1995).
8. 31P MR spectroscopy data. Magn. Reson. Med. 34, 664-672 (1995).
9. 1H spectra of thyroid neoplasms. Magn. Reson. Med. 33, 257-263 (1995).
10. 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 1, 1597-1600 (1996).
11. 1H NMR data of human plasma. NMR Biomed. 8, 235-244 (1995).
12. 1H nuclear magnetic resonance spectroscopic data from human plasma. Anticancer Res. 16, 1473-1478 (1996).
13. Long J. R., Gregoriou V. G. and Gemperline P. J. Spectroscopic calibration and quantitation using artificial neural networks. Anal. Chem. 62, 1791-1797 (1990).
14. Bos M., Bos A. and van der Linden W. E. Data processing by neural networks in quantitative chemical analysis. Analyst 118, 323-328 (1993).
15. 1H NMR data from human blood plasma. J. Magn. Reson. B 106, 191-194 (1995).
16. 31P NMR pig liver study. Magn. Reson. Med., 38, 840-844 (1997).
17. 1H MRS data from human brain. Proceedings of the 4th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Abstr., p. 1190 (1996).
18. Videen J. S. Training an artificial neural network to interpret model brain proton spectra. Proceedings of the 4th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Abstr. p. 1171 (1996).
19. 1H NMR based quantitation of human lipoproteins and their lipid contents directly from plasma. J. Lipid Res. 35, 2292-2304 (1994).
20. Fredrickson D. S., Levy R. I. and Lees R. S. Fat transport in lipoproteins - an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 34-42 (1967).
21. Study Group, European Atherosclerosis Society. The recognition and management of hyperlipidemia in adults. Eur. Heart J. 9, 571-600 (1988).
22. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
23. Lipid Research Clinics Program, Manual of laboratory operations. Lipid and lipoprotein analysis. DHEW publications (NIH) 1, 56-57 (1974).
24. Otvos J. D., Jeyarajah E. J., Bennett D. W. and Krauss R. M. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38, 1632-1638 (1992).
25. 1H NMR spectroscopy of human blood plasma. Progr. Nucl. Magn. Reson. Spectr. 27, 475-554 (1995).
26. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 67, 793-811 (1995).
27. 1H NMR and prior knowledge based lineshape fitting analysis: a powerful combination for quantitative biochemistry of plasma and lipoproteins. J. Magn. Reson. Anal. 3, 15-20 (1997).
28. Bell J. D., Barnard M. L., Parkes H. G., Thomas E. L., Brennan C. H., Cunnane S. C. and Dagnelie P. C. Effects of n-3 fatty acids on the NMR profile of plasma lipoproteins. J. Lipid Res. 37, 1664-1674 (1996).
29. Lounila J., Ala-Korpela M., Jokisaari J., Savolainen M. J. and Kesäniemi Y. A. Effects of orientational order and particle size on the NMR line positions of lipoproteins. Phys. Rev. Lett. 72, 4049-4052 (1994).
30. Schuchhardt J., Schneider G., Reichelt J., Schomburg D. and Wrede P. Local structural motifs of protein backbones are classified by self-organizing neural networks. Prot. Engineering 9, 833-842 (1996).
31. Kohonen T., Hynninen J., Kangas J. and Laaksonen J. SOM_PAK: The self-organizing map program package. Helsinki University of Technology, Laboratory of Computer and Information Science (1995).
32. Brown M. S., Kovanen P. T. and Goldstein J. L. Regulation of plasma cholesterol by lipoprotein receptors. Science 212, 628-635 (1981).
33. Austin M. A. Epidemiologic associations between hypertriglyceridemia and coronary heart disease. Semin. Thromb. Hemost. 14, 137-142 (1988).
34. Manninen V., Elo O., Prick H., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Mäenpää H., Mälkönen M., Mänttäri M., Norola S., Pasternack A., Pikkarainen J., Romo M., Sjöblom T. and Nikkilä E. A. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260, 641-651 (1988).
35. Tall A. R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86, 379-384 (1990).
36. Tenkanen L., Pietila K., Manninen V. and Mänttäri M. The triglyceride issue revisited: findings from the Helsinki Heart Study. Arch. Intern. Med. 154, 2714-2720 (1994).
37. McGill, Jr. H. C. Overview. In Atherosclerosis and Coronary Artery Disease, ed. by V. Fuster, R. Ross and E. J. Topol, vol. 1, pp. 25-41. Lippincott-Raven Publishers, Philadelphia, PA (1996).
38. Grundy S. M. Lipids, nutrition, and coronary heart disease. In Atherosclerosis and Coronary Artery Disease, ed. by V. Fuster, R. Ross and E. J. Topol, vol. 1, pp 45-68. Lippincott-Raven Publishers, Philadelphia, PA (1996).